Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 200898
Company: ALVOGEN

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
EXEMESTANE EXEMESTANE 25MG TABLET;ORAL Prescription AB No No

Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
07/28/2014 ORIG-1 Approval

Label is not available on this site.
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
02/22/2019 SUPPL-10 Labeling-Patient Package Insert, Labeling-Package Insert

Label is not available on this site.
02/22/2019 SUPPL-6 Labeling-Package Insert, Labeling-Patient Package Insert

Label is not available on this site.

EXEMESTANE

TABLET;ORAL; 25MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
AROMASIN EXEMESTANE 25MG TABLET;ORAL Prescription Yes AB 020753 PHARMACIA AND UPJOHN
EXEMESTANE EXEMESTANE 25MG TABLET;ORAL Prescription No AB 200898 ALVOGEN
EXEMESTANE EXEMESTANE 25MG TABLET;ORAL Prescription No AB 210323 CIPLA
EXEMESTANE EXEMESTANE 25MG TABLET;ORAL Prescription No AB 077431 HIKMA
EXEMESTANE EXEMESTANE 25MG TABLET;ORAL Prescription No AB 208764 MAYNE PHARMA INC
EXEMESTANE EXEMESTANE 25MG TABLET;ORAL Prescription No AB 203315 MYLAN
EXEMESTANE EXEMESTANE 25MG TABLET;ORAL Prescription No AB 209208 UPSHER SMITH LABS
EXEMESTANE EXEMESTANE 25MG TABLET;ORAL Prescription No AB 202602 ZYDUS PHARMS

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English